Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Molecular Weight | 556.6 g/mol |
---|---|
Molecular Formula | C29H36N2O9-2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 556.24208073 g/mol |
Monoisotopic Mass | 556.24208073 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 40 |
Formal Charge | -2 |
Complexity | 724 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Ivabradine Oxalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivabradine Oxalate, including repackagers and relabelers. The FDA regulates Ivabradine Oxalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivabradine Oxalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ivabradine Oxalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ivabradine Oxalate supplier is an individual or a company that provides Ivabradine Oxalate active pharmaceutical ingredient (API) or Ivabradine Oxalate finished formulations upon request. The Ivabradine Oxalate suppliers may include Ivabradine Oxalate API manufacturers, exporters, distributors and traders.
click here to find a list of Ivabradine Oxalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ivabradine Oxalate written confirmation (Ivabradine Oxalate WC) is an official document issued by a regulatory agency to a Ivabradine Oxalate manufacturer, verifying that the manufacturing facility of a Ivabradine Oxalate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ivabradine Oxalate APIs or Ivabradine Oxalate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ivabradine Oxalate WC (written confirmation) as part of the regulatory process.
click here to find a list of Ivabradine Oxalate suppliers with Written Confirmation (WC) on PharmaCompass.
Ivabradine Oxalate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ivabradine Oxalate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ivabradine Oxalate GMP manufacturer or Ivabradine Oxalate GMP API supplier for your needs.
A Ivabradine Oxalate CoA (Certificate of Analysis) is a formal document that attests to Ivabradine Oxalate's compliance with Ivabradine Oxalate specifications and serves as a tool for batch-level quality control.
Ivabradine Oxalate CoA mostly includes findings from lab analyses of a specific batch. For each Ivabradine Oxalate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ivabradine Oxalate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ivabradine Oxalate EP), Ivabradine Oxalate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ivabradine Oxalate USP).
LOOKING FOR A SUPPLIER?